Teladoc Health (Brazil) Performance
| T2DH34 Stock | BRL 1.99 0.05 2.45% |
On a scale of 0 to 100, Teladoc Health holds a performance score of 6. The entity has a beta of 0.87, which indicates possible diversification benefits within a given portfolio. Teladoc Health returns are very sensitive to returns on the market. As the market goes up or down, Teladoc Health is expected to follow. Please check Teladoc Health's sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether Teladoc Health's existing price patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Teladoc Health are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Teladoc Health sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 733.3 M | |
| Total Cashflows From Investing Activities | -73 M |
Teladoc |
Teladoc Health Relative Risk vs. Return Landscape
If you would invest 169.00 in Teladoc Health on November 3, 2024 and sell it today you would earn a total of 30.00 from holding Teladoc Health or generate 17.75% return on investment over 90 days. Teladoc Health is generating 0.3695% of daily returns and assumes 4.4028% volatility on return distribution over the 90 days horizon. Simply put, 39% of stocks are less volatile than Teladoc, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Teladoc Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Teladoc Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Teladoc Health, and traders can use it to determine the average amount a Teladoc Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0839
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | T2DH34 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.4 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Teladoc Health is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teladoc Health by adding it to a well-diversified portfolio.
Teladoc Health Fundamentals Growth
Teladoc Stock prices reflect investors' perceptions of the future prospects and financial health of Teladoc Health, and Teladoc Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Teladoc Stock performance.
| Return On Equity | -0.89 | |||
| Return On Asset | -0.0113 | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | 27.98 B | |||
| Shares Outstanding | 161.93 M | |||
| Price To Book | 0.03 X | |||
| Price To Sales | 10.12 X | |||
| Revenue | 2.03 B | |||
| EBITDA | (84.67 M) | |||
| Cash And Equivalents | 722.63 M | |||
| Cash Per Share | 4.68 X | |||
| Total Debt | 1.23 B | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 37.32 X | |||
| Cash Flow From Operations | 193.99 M | |||
| Earnings Per Share | (223.95) X | |||
| Total Asset | 17.73 B | |||
About Teladoc Health Performance
By analyzing Teladoc Health's fundamental ratios, stakeholders can gain valuable insights into Teladoc Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Teladoc Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Teladoc Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York. TELADOCHEALTDRN operates under Health Information Services classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 3652 people.Things to note about Teladoc Health performance evaluation
Checking the ongoing alerts about Teladoc Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Teladoc Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Teladoc Health may become a speculative penny stock | |
| Teladoc Health had very high historical volatility over the last 90 days | |
| The company reported the revenue of 2.03 B. Net Loss for the year was (428.79 M) with profit before overhead, payroll, taxes, and interest of 1.38 B. |
- Analyzing Teladoc Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Teladoc Health's stock is overvalued or undervalued compared to its peers.
- Examining Teladoc Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Teladoc Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Teladoc Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Teladoc Health's stock. These opinions can provide insight into Teladoc Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Teladoc Stock analysis
When running Teladoc Health's price analysis, check to measure Teladoc Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc Health is operating at the current time. Most of Teladoc Health's value examination focuses on studying past and present price action to predict the probability of Teladoc Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc Health's price. Additionally, you may evaluate how the addition of Teladoc Health to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |